FGK Clinical Research GmbH
FGK Clinical Research GmbH is a Private limited company (Ltd.) registered in Germany under HRB 144089 München, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is München, Germany. 5 shareholders are on record for FGK Clinical Research GmbH, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 22 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for FGK Clinical Research GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Mackess GmbH, holding 25% — the largest recorded stake — followed by Mackess GmbH at 25%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 7 shareholders in total, though only the top 5 by holding are shown in this view.
4 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Mackess GmbH | 25% | Handelsregister (Commercial Register) | |
| Mackess GmbH | 25% | Handelsregister (Commercial Register) | |
| Edgar Josef Fenzl | 18% | Handelsregister (Commercial Register) | |
| FischGlas GmbH | 10% | Handelsregister (Commercial Register) | |
| KADO GmbH | 10% | Handelsregister (Commercial Register) |
Officers
5
Four of the 5 officer records shown for FGK Clinical Research GmbH are current appointments, filed with Handelsregister (Commercial Register). Martin Krauß serves as Geschäftsführer (director); Heiko Debus (appointed 2018-08-28), Ursula Türcke (appointed 2018-08-28) and Olaf Böhm (appointed 2018-08-28) all serve as Officer. The remaining 1 record shown (Edgar Josef Fenzl) is a former appointment that has since been resigned.
The register reports 7 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at FGK Clinical Research GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
FGK Clinical Research GmbH sits 1 level below its ultimate parent, Mackess GmbH, registered in Germany. 6 subsidiaries are recorded beneath it, across 5 jurisdictions. Immediately above FGK Clinical Research GmbH is Mackess GmbH, holding 50% as filed in FGK Clinical Research GmbH's own shareholder record with Handelsregister (Commercial Register). Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 6 subsidiaries span Germany, Poland, Hungary, United Kingdom, Czechia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Mackess GmbH
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns FGK Clinical Research GmbH?
Five shareholders are currently on record for FGK Clinical Research GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Mackess GmbH, holding 25% — the largest recorded stake — followed by Mackess GmbH at 25%; the remaining 3 shareholders shown hold smaller stakes. 4 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is FGK Clinical Research GmbH's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for FGK Clinical Research GmbH is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does FGK Clinical Research GmbH have on record?
5 shareholders are shown on record for FGK Clinical Research GmbH. The register reports 7 in total; only the top 5 by holding are shown here.
What is FGK Clinical Research GmbH's company registration number?
FGK Clinical Research GmbH's registration number is HRB 144089 München, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is FGK Clinical Research GmbH still an active company?
FGK Clinical Research GmbH's status on Handelsregister (Commercial Register) is listed as active.
What is FGK Clinical Research GmbH's registered address?
The registered address on file for FGK Clinical Research GmbH is München, Germany.
Who are the officers/directors of FGK Clinical Research GmbH?
Four of the 5 officer records shown for FGK Clinical Research GmbH are current appointments, filed with Handelsregister (Commercial Register). Martin Krauß serves as Geschäftsführer (director); Heiko Debus (appointed 2018-08-28), Ursula Türcke (appointed 2018-08-28) and Olaf Böhm (appointed 2018-08-28) all serve as Officer. The remaining 1 record shown (Edgar Josef Fenzl) is a former appointment that has since been resigned. Management authority at FGK Clinical Research GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does FGK Clinical Research GmbH have a parent company or subsidiaries?
FGK Clinical Research GmbH sits 1 level below its ultimate parent, Mackess GmbH, registered in Germany. 6 subsidiaries are recorded beneath it, across 5 jurisdictions. Those 6 subsidiaries span Germany, Poland, Hungary, United Kingdom, Czechia jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to FGK Clinical Research GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to FGK Clinical Research GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access FGK Clinical Research GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like FGK Clinical Research GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 22 October 2026.